Cargando…

Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial

Hypertension is highly prevalent among the Lebanese adult population and is indeed the major cause of mortality in Lebanon. Traditional use of antihypertensive medicinal plants has long been practiced. The aim of this study is to document this traditional knowledge and clinically test the antihypert...

Descripción completa

Detalles Bibliográficos
Autores principales: Samaha, Ali A., Fawaz, Mirna, Salami, Ali, Baydoun, Safaa, Eid, Ali H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681041/
https://www.ncbi.nlm.nih.gov/pubmed/31330767
http://dx.doi.org/10.3390/biom9070292
_version_ 1783441641075376128
author Samaha, Ali A.
Fawaz, Mirna
Salami, Ali
Baydoun, Safaa
Eid, Ali H.
author_facet Samaha, Ali A.
Fawaz, Mirna
Salami, Ali
Baydoun, Safaa
Eid, Ali H.
author_sort Samaha, Ali A.
collection PubMed
description Hypertension is highly prevalent among the Lebanese adult population and is indeed the major cause of mortality in Lebanon. Traditional use of antihypertensive medicinal plants has long been practiced. The aim of this study is to document this traditional knowledge and clinically test the antihypertensive capacity of three of the most commonly used wild plant species Mentha longifolia, Viola odorata and Urtica dioica. Ethno-pharmacological data was collected by personal interviews with herbalists and traditional healers using a semi structured survey questionnaire and assessing relative frequency of citation (RFC). The clinical study was conducted by a randomized, blind, placebo-controlled trial in 29 subjects with mild hypertension distributed in four groups, three plant extract treatments and one placebo. Systolic (SBP) and diastolic blood pressures (DBP) as well as mean arterial blood pressures (MAP) were monitored at weeks 4, 8, 12 and 16 during the treatment with 300 mL/day of plant extract. Results showed that M. longifolia, U. dioica and V. odorata exhibited the highest values of RCF (0.95) followed by Allium ampeloprasum (0.94), Apium graveolens (0.92) and Crataegus azarolus (0.90). The clinical trial revealed dose- and duration-dependent significant reductions in SBP, DBP and MAP of subjects treated with M. longifolia, U. dioica or V. odorata. Our findings indicate that extracts of these plants present an effective, safe and promising potential as a phyto-therapuetical approach for the treatment of mild hypertension. More research on the phytochemistry, pharmacological effects and the underlying mechanisms is necessary.
format Online
Article
Text
id pubmed-6681041
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66810412019-08-09 Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial Samaha, Ali A. Fawaz, Mirna Salami, Ali Baydoun, Safaa Eid, Ali H. Biomolecules Article Hypertension is highly prevalent among the Lebanese adult population and is indeed the major cause of mortality in Lebanon. Traditional use of antihypertensive medicinal plants has long been practiced. The aim of this study is to document this traditional knowledge and clinically test the antihypertensive capacity of three of the most commonly used wild plant species Mentha longifolia, Viola odorata and Urtica dioica. Ethno-pharmacological data was collected by personal interviews with herbalists and traditional healers using a semi structured survey questionnaire and assessing relative frequency of citation (RFC). The clinical study was conducted by a randomized, blind, placebo-controlled trial in 29 subjects with mild hypertension distributed in four groups, three plant extract treatments and one placebo. Systolic (SBP) and diastolic blood pressures (DBP) as well as mean arterial blood pressures (MAP) were monitored at weeks 4, 8, 12 and 16 during the treatment with 300 mL/day of plant extract. Results showed that M. longifolia, U. dioica and V. odorata exhibited the highest values of RCF (0.95) followed by Allium ampeloprasum (0.94), Apium graveolens (0.92) and Crataegus azarolus (0.90). The clinical trial revealed dose- and duration-dependent significant reductions in SBP, DBP and MAP of subjects treated with M. longifolia, U. dioica or V. odorata. Our findings indicate that extracts of these plants present an effective, safe and promising potential as a phyto-therapuetical approach for the treatment of mild hypertension. More research on the phytochemistry, pharmacological effects and the underlying mechanisms is necessary. MDPI 2019-07-20 /pmc/articles/PMC6681041/ /pubmed/31330767 http://dx.doi.org/10.3390/biom9070292 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Samaha, Ali A.
Fawaz, Mirna
Salami, Ali
Baydoun, Safaa
Eid, Ali H.
Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial
title Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial
title_full Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial
title_fullStr Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial
title_full_unstemmed Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial
title_short Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial
title_sort antihypertensive indigenous lebanese plants: ethnopharmacology and a clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681041/
https://www.ncbi.nlm.nih.gov/pubmed/31330767
http://dx.doi.org/10.3390/biom9070292
work_keys_str_mv AT samahaalia antihypertensiveindigenouslebaneseplantsethnopharmacologyandaclinicaltrial
AT fawazmirna antihypertensiveindigenouslebaneseplantsethnopharmacologyandaclinicaltrial
AT salamiali antihypertensiveindigenouslebaneseplantsethnopharmacologyandaclinicaltrial
AT baydounsafaa antihypertensiveindigenouslebaneseplantsethnopharmacologyandaclinicaltrial
AT eidalih antihypertensiveindigenouslebaneseplantsethnopharmacologyandaclinicaltrial